SYMPOSIUM 1 - LILLY
Chair: Prof. Dr. med Martin Haluzik
Prof. Dr. med Martin Haluzik: The Need for proactive, comprehensive treatment of T2D and Obesity
Prof. Dr. med Tomasz Klupa: Targeting Adiposity as a Root Cause for T2D and Obesity
Dr. med Dr. Laxmi Narsimha Rao: New Horizons in Obesity Care
Prof. Dr. med Klupa: Incretin co-agonists in the Treatment of T2D
Panel Discussion
SYMPOSIUM 2 - ZENTIVA
Chair: R. Češka
L. Tokgözoğlu (Ankara, Turkey) How to get to LDL-C goal in the multimorbid patients?
A. Zambon (Padova, Italy) Beyond the usual suspects: TG-rich lipoproteins and Lp(a)
K. Narkiewicz (Gdansk, Poland) The silent killers: Advanced strategies for hypertension and obesity management
SYMPOSIUM 3 - DIGITAL MEDICINE
I. Said Criado (Ponteverda, Spain) - New Skills to adress Digital Medicine
M. Prázný (Prague, Czech Republic) - Digital diabetology: fiction or reality?
J. Škrha jr. (Prague, Czech Republic) - Can AI help in the postgraduate education and research?
SYMPOSIUM 4 - WÖRWAG PHARMA
R. Češka (Prague, Czech Republic) Optimizing Patient Care: Strategies for Managing Vitamin B12 Deficiency in Internal Medicine
R. Obeid (Hamburg, Germany) Practical Guidance for Diagnosing and Treating Vitamin B12 Deficiency: Results of an International and Multidisciplinary B12 Consensus Conference
B. Hooshmand (Tutzing, Germany) Vitamin B12 in Neurology: A Clinical Approach
SYMPOSIUM 5 - SANOFI
Chair: R. Češka
A. Linhart (Prague, Czech Republic) - Dyslipidemia - an underappreciated risk factor in the context of a high-risk country
M. Vrablík (Prague, Czech Republic) - Fail no more. Lipid goals at our hands.
M. Kaluzna-Oleksy (Poznan, Poland) - Complex ACS management - the place of lipid lowering therapy and rehabilitation – learnings from MACAMIS program in Poland - ACS forum like an experience exchange platform
SYMPOSIUM 6 - ISIM
C. Arias (Santo Domingo, Dominican Republic) Monkeypox
Q. T. Islam (Dhaka, Bangladesh) Emergencies in Dengue Syndrome
A. C. Cejudo (Mexico City, Mexico) Inflammatory process and the risk factors for cardiovascular diseases
E. Topinková (Prague, Czech Republic) Geriatrics
SYMPOSIUM 7 - AMGEN
Chair: R. Češka
R. Češka (Prague, Czech Republic) - Introduction
L. Tokgözoğlu (Ankara, Turkey) - CV risk reduction with lipid lowering: When and how?
M. Vrablík (Prague, Czech Republic) - The Power of Low LDL-C: Who Benefits Most and How Low is Enough
A. Zambon (Padova, Italy) - From research to clinical settings: PCSK9i Real Life Experience in Europe
SYMPOSIUM 8 - NOVARTIS LP(a)
Chairs: M. Vrablík, R. Češka
L. Tokgozoglu (Ankara, Turkey) ...The global problem
A. Zambon (Padova, Italy) ... and CVD risk
P. Lansberg (Amsterdam, Netherlands) ... and therapeutic approach
M. Banach (Lodz, Poland)
R. Češka (Prague, Czech Republic)
K. Čillíkova (Czech Republic)
P. Lansberg (Amsterdam, Netherlands)
M. Rizzo (Palermo, Italy)
L. Tokgozoglu (Ankara, Turkey)
A. Zambon (Padova, Italy)
PRAGUE - THE CAPITAL OF INTERNAL MEDICINE 2024